Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study
ConclusionsStatins significantly reduced the risk of major bleeding, all-cause mortality, and ischemic events in patients with NVAF taking OACs. Their additive benefits should be considered in routine practice and thus be further researched.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Valve Disease | Heart Valves | Hemorrhagic Stroke | History of Medicine | Hypertension | Ischemic Stroke | Japan Health | Pulmonary Thromboembolism | Statin Therapy | Stroke | Study | Thrombosis